Watch Ticker

Perspective Therapeutics, Inc.

Go to Perspective Therapeutics, Inc. Website

$3.89

0.21 (5.71%)

Live

Previous Close

$3.68

Day Range

$3.65 - $3.91

Previous Day Range

$3.65 - $3.83

Market Cap

$273.2 million USD

Day Vol.

421718

Previous Day Vol.

686930

Currency

USD

Primary Exchange

NYSE American, LLC

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds

Despite regulatory challenges and budget cuts, the oncology market is projected to reach US$900 billion by 2034, with several biotech companies advancing innovative cancer therapies and demonstrating promising clinical trial results.

Related tickers: ONCY, CUE, VSTM, ALLO, CATX.

Read Full Article

Perspective Therapeutics - Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2025 Financial Results

Perspective Therapeutics, a radiopharmaceutical company, will report its Q2 2025 financial results on August 13, 2025, focusing on advanced cancer treatments using alpha-emitting isotope 212Pb and developing complementary imaging diagnostics.

Related tickers: CATX.

Read Full Article

Trending Tickers

Please sign in to view